Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Interfacing With NeuroTechnology to Expand Neural Throughput (INTENT)

NCT: NCT07521930 · RECRUITING

NCT IDNCT07521930
StatusRECRUITING
Start Date2026-06
Completion2028-12

Brief Summary

The goal of this clinical trial is to evaluate the safety and preliminary efficacy of an implantable device that records and stimulates different areas of the brain to allow adults affected by disabling paralysis (see Eligibility for more details) to control and receive feedback from assistive devices.

Frequently Asked Questions

What is Interfacing With NeuroTechnology to Expand Neural Throughput (INTENT)?

Interfacing With NeuroTechnology to Expand Neural Throughput (INTENT) is a clinical trial registered under NCT07521930. Current status: RECRUITING.

What is the status of NCT07521930?

The current status of NCT07521930 (Interfacing With NeuroTechnology to Expand Neural Throughput (INTENT)) is: RECRUITING.

When did Interfacing With NeuroTechnology to Expand Neural Throughput (INTENT) start?

Interfacing With NeuroTechnology to Expand Neural Throughput (INTENT) started on 2026-06.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.